Informação da revista
Vol. 42. Núm. 4.
Páginas 291-294 (abril 2023)
Partilhar
Partilhar
Baixar PDF
Mais opções do artigo
Vol. 42. Núm. 4.
Páginas 291-294 (abril 2023)
Editorial
Acesso de texto completo
The Portuguese Journal of Cardiology: Is the glass half full or half empty?
Revista Portuguesa de Cardiologia: está o copo meio cheio ou meio vazio?
Visitas
1262
Helena Donatoa, Nuno Cardimb,
Autor para correspondência
cardimnuno@gmail.com

Corresponding author.
a Documentation and Scientific Information Service, Centro Hospital e Universitário de Coimbra, Coimbra, Portugal
b Editor-in Chief-Portuguese Journal of Cardiology, Serviço de Cardiologia Hospital CUF Descobertas, Lisbon, Portugal
Este item recebeu
Informação do artigo
Texto Completo
Bibliografia
Baixar PDF
Estatísticas
Figuras (2)
Texto Completo

The Portuguese Journal of Cardiology's (RPC) impact factor (IF) for the year 2021 was 1.651, a record number following an increase from 0.96 in 2019 to 1.374 in 2020 (Figure 1).

Figure 1.

The Portuguese Journal of Cardiology impact factor over time.

(0,11MB).

This consistent increase reflects the commitment of the whole editorial team (editors, editorial board members, multimedia team, an editorial and bibliographic consultant, editorial assistants, translators, and publisher): a good example of teamwork. However, it also reflects the generosity of our reviewers, giving their time to perform high quality reviews. We encourage reviewers to access the benefits to which they are entitled (in an editorial published in 20211). And finally, we obviously thank the authors who choose the RPC to publish their work (Figure 2).1–3

Figure 2.

Origin (countries/regions) with more articles published in RPC.

(0,09MB).

However, although at first sight the impact factor (IF) figures (Figure 1) look promising and encouraging, they need to be put into context. First, in the last year, because of several factors, including the SARS-CoV-2 pandemic, many medical journals increased their IF.4 Second, the relative position of our Journal among the Cardiac and Cardiovascular Systems journals remains poor, currently still in the quartile 4, ranked 128/143 (one hundred and twenty-eighth out of one hundred and forty-three) rising from 136/142 last year. Improving our position in the ranking and changing our quartile should be one of our major aims in the coming years.

While we still do not yet know our 2022 IF, it is important to assess in which direction we are going. As a reminder, the most cited papers published in 2020 and 2021 and therefore those that contribute to the 2022 IF are, to date:

  • -

    16 citations: Gouveia MR, Ascenção RM, Fiorentino F, Costa JN, Broeiro-Gonçalves PM, Fonseca MC, Borges MFPF. Current costs of heart failure in Portugal and expected increases due to population aging. Rev Port Cardiol. 2020;39:3–11.5

  • -

    10 citations: Coelho SG, Almeida AG. Marfan syndrome revisited: from genetics to the clinic. Rev Port Cardiol. 2020;39:215–26.6

  • -

    9 citations: Cekirdekci EI, Bugan B. Whole blood viscosity in microvascular angina and coronary artery disease: significance and utility. Rev Port Cardiol. 2020;39:17–23.7

  • -

    8 citations: Guiomar N, Vaz-da-Silva M, Mbala D, Sousa-Pinto B, Monteiro JP, Ponce P, Carneiro F, M Guerra, Neves F, Ferraz R, Rijo D, Teixeira M, Vouga L, Braga P. Cardiac surgery in infective endocarditis and predictors of in-hospital mortality. Rev Port Cardiol. 2020;39:137–49.8

  • -

    7 citations: Tascanov MB, Tanriverdi Z, Gungoren F, Besli F, Erkus ME, Altiparmak İH, Gonel A, Koyuncu I, Demirbag R. Relationships between paroxysmal atrial fibrillation, total oxidant status, and DNA damage. Rev Port Cardiol. 2021;40:5–10.9

As it is widely known, the major determinant of the IF is the number of citations for papers published in the two previous years. In recent research we have noticed that many prestigious high IF international journals have cited articles published in our journal; unfortunately, the opposite is not often true, as Portuguese cardiologists publishing in international journals often ignore the RPC and forget to cite papers from their national journal.

In 2023, we call on authors to explore the different types of manuscripts our Journal accepts (Table 1) and to increase submissions that improve communication and discussion of relevant topics as well as of published articles; accordingly, study protocols, commentary pieces, letters to the editor, research letters, snapshots, and images in Cardiology (these last two will substitute case reports, which are no longer being accepted) will be welcome. Another important type of article is the current perspective, with reports on issues of general interest, such as political aspects affecting the profession, health economics, inequality in healthcare, national health care systems and other issues in cardiology advocacy.

Table 1.

Article types accepted by Portuguese Journal of Cardiology in 2023.

Article type  Abstract  Keywords  Main text structure  Max. words  Tables/figures  References 
Original Article  Max. 250 words; structured (Introduction and Objectives, Methods, Results and Conclusion(s))  3–10  Introduction; Objectives; Methods; Results; Discussion; Conclusion(s); Learning points/Take home messages; Acknowledgments, if any; References; Central figure, figure legends  4000+100 (learning points)  Total up to 10  up to 50 
Review Article  Max. 250 words; unstructured  3–10  Introduction; thematic sections at the discretion of the authors; Conclusion(s); Acknowledgments, if any; References; and figure legends, if any  5000  Total up to 15  up to 75 
Systematic Review with or without Meta-analysis  Max. 300 words; Structured  3–10  Introduction, Methods, Results, Discussion and Conclusion(s); Acknowledgments, if any; References; and figure legends, if any (PRISMA)  4000  Total up to 6  Up to 100 
Images in Cardiology  None  None  Unstructured  250  Up to 2 figures; no tables  Up to 5 
Editorial Comment  None  None  Unstructured  1000  1 table, 1 figure+photo of the author  Up to 20 
Letter to the Editor  None  None  Unstructured  600  Up to 2 figures; no tables  Up to 5 
Guidelines  Max. 350 words; unstructured  3–10  Introduction; thematic sections at the discretion of the authors; Conclusion(s); Acknowledgments, if any; References; and figure legends, if any  4000  Total up to 6  Up to 100 
Current Perspectives  None  3–6  Unstructured  1200  Up to 2  Up to 10 
Observational or Research Letter  None  3–6  Unstructured  600  Up to 2  Up to 6 
Study Protocols  Max. 300 words; Structured  3–10  PRISMA-P or SPIRIT  4000  Up to 3  Up to 30 

Another interesting ideas for the near future will be “press releases” of the most impactful articles and podcasts in which guest authors, reviewers, top clinicians, scientists are interviewed to discuss their research and/or comment on selected articles that cannot be used for reading.

High quality original articles will also play a major role (conventional publication, ahead of print, and fast track for selected original article submissions) and the digital attention received by the articles is assessed using multiple online sources, employing PlumX metrics.

We are committed to publishing relevant, accurate and state-of-the-art articles and adhere to the highest ethical and editorial principles. The RPC subscribes to the recommendations of the International Committee of Medical Journal Editors for the conduct, reporting, editing and publication of scholarly work in biomedical journals. The Journal is also a registered member of the Committee on Publication Ethics and follows the Committee's guidelines. Our Journal also meets open science requirements and is aligned with the strong demand from funding agencies. The RPC is an open access journal that does not charge article processing fees. It is compliant with Plan S, the mandate for open access publishing laid out by Coalition S, a large group of governmental and philanthropic funders. Authors whose research is supported by these agencies need to commit to publishing their paper in open access journals.

However, our aim is not only the publication of good material and the increase in the Journal's impact factor but also, we are striving to further strengthen the links between editors, authors, reviewers, and readers through a series of coordinated and diverse actions and activities. These include the organization of webinars and meetings to discuss articles, an active presence on social media and participation in congresses around the world.

Conflicts of interest

The authors have no conflicts of interest to declare.

References
[1]
H. Donato, N. Cardim.
Open letter to our reviewers: justice is needed!.
Rev Port Cardiol, 40 (2021), pp. 1-3
[2]
H. Donato, N. Cardim.
The impact factor addiction: facts and fiction.
Rev Port Cardiol, 39 (2020), pp. 361-364
[3]
F. Crea.
Impact factor of the European heart journal: update, interpretation, and perspectives.
Eur Heart J, 42 (2021), pp. 3214-3215
[4]
A. Maillard, T. Delory.
Blockbuster effect of COVID-19 on the impact factor of infectious disease journals.
Clin Microbiol Infect., 28 (2022), pp. 1536-1538
[5]
M.R. Gouveia, R.M. Ascenção, F. Fiorentino, et al.
Current costs of heart failure in Portugal and expected increases due to population aging.
Rev Port Cardiol, 39 (2020), pp. 3-11
[6]
S.G. Coelho, A.G. Almeida.
Marfan syndrome revisited: from genetics to the clinic.
Rev Port Cardiol, 39 (2020), pp. 215-226
[7]
E.I. Cekirdekci, B. Bugan.
Whole blood viscosity in microvascular angina and coronary artery disease: significance and utility.
Rev Port Cardiol, 39 (2020), pp. 17-23
[8]
N. Guiomar, M. Vaz-da-Silva, D. Mbala, et al.
Cardiac surgery in infective endocarditis and predictors of in-hospital mortality.
Rev Port Cardiol, 39 (2020), pp. 137-149
[9]
M.B. Tascanov, Z. Tanriverdi, F. Gungoren, et al.
Relationships between paroxysmal atrial fibrillation, total oxidant status, and DNA damage.
Rev Port Cardiol, 40 (2021), pp. 5-10
Copyright © 2023. Sociedade Portuguesa de Cardiologia
Idiomas
Revista Portuguesa de Cardiologia
Opções de artigo
Ferramentas
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Ao assinalar que é «Profissional de Saúde», declara conhecer e aceitar que a responsável pelo tratamento dos dados pessoais dos utilizadores da página de internet da Revista Portuguesa de Cardiologia (RPC), é esta entidade, com sede no Campo Grande, n.º 28, 13.º, 1700-093 Lisboa, com os telefones 217 970 685 e 217 817 630, fax 217 931 095 e com o endereço de correio eletrónico revista@spc.pt. Declaro para todos os fins, que assumo inteira responsabilidade pela veracidade e exatidão da afirmação aqui fornecida.